查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1826928

2025年全球基因面板市场报告

Gene Panel Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基因检测市场规模迅速扩张，从2024年的21.4亿美元成长到2025年的24.7亿美元，复合年增长率为15.2%。预测期内的成长可归因于遗传病患病率的上升、基因筛检需求的增加、研发活动的增加、先天性疾病盛行率的上升以及对先进治疗方案的需求的不断增长。

预计未来几年基因检测市场将快速成长，到2029年将达到43.3亿美元，年复合成长率（CAGR）为15.1%。预测期内的成长主要受以下因素驱动：慢性病发生率上升、癌症盛行率上升、基因检测意识增强、政府措施以及医疗支出成长。预测期内的主要趋势包括基因检测技术的进步、策略合作、个人化医疗、人工智慧的整合以及先进的生物资讯学工具。

基因面板是一组选定的特定基因，用于在单次检测中检测，以分析与特定疾病或病症相关的遗传变异。基因面板用于遗传疾病诊断、遗传疾病检测，并透过同时检测多个基因来制定个人化治疗方案，特别适用于癌症、罕见疾病和其他遗传性疾病。

我们主要的基因检测产品和服务包括检测套组和检测服务。检测套组是包含所有基因分析所需试剂和说明书的包装工具。这些检测试剂盒采用扩增子和杂合反应等多种技术，并提供预先设计或客製化版本。我们的检测试剂盒应用于癌症风险评估、先天性疾病诊断和药物基因等领域，服务研究机构、医院、诊断中心和製药公司等终端用户。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗保健提供者正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨，其中许多产品的国内替代品有限。这些不断上涨的成本使医疗保健预算捉襟见肘，导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，造成供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供基因面板市场统计数据，例如基因面板行业的全球市场规模、各地区份额、各竞争对手的市场份额、详细的基因面板细分市场、市场趋势和机会，以及在基因面板行业取得成功所需的数据。本基因面板市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

未来五年15.1%的成长预测较先前的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国，因为这将增加来自韩国和英国的次世代定序的成本，从而延迟遗传疾病的诊断，并增加分子病理学实验室的支出。由于互惠关税以及贸易紧张局势和限制措施的加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

癌症盛行率的上升预计将推动基因面板市场的成长。癌症是一组以异常细胞不受控制地生长和扩散为特征的疾病，这些细胞会侵入并损害周围的组织和器官。人口老化、生活方式的改变、环境暴露以及检测和诊断技术的进步等因素导致癌症患者数量不断增加。基因面板在癌症诊断中发挥关键作用，它可以透过全面的基因检测来识别特定的基因突变和变异，从而促进个人化治疗策略并改善患者预后。例如，2024年2月，总部位于瑞士的政府间组织世界卫生组织（WHO）报告称，预计2022年将有970万人死于癌症，并新增2,000万例癌症病例。肺癌是最常见的癌症，占新增病例的12.4%，全球确诊人数为250万人。癌症盛行率的上升持续推动基因面板检测的需求。

基因面板市场的主要企业正致力于开发先进的肿瘤学面板，以提高癌症诊断和个人化治疗方法的准确性、效率和全面性。肿瘤学面板是专门的基因面板，可分析多个癌症相关基因并识别基因突变和变异，以辅助诊断、预后和治疗计划。例如，美国生物技术公司Vizgen Inc.于2023年5月推出了MERFISH PanCancer Pathways Panel，为研究太空基因组学的科学家提供可客製化的选项。这些预先设计的面板针对包括癌症研究在内的各种研究应用进行了最佳化，并增强了误差稳健性，从而获得可靠且可重复的结果。透过将空间资讯与基因表现数据结合，该面板可以深入了解肿瘤微环境和细胞间相互作用，从而促进靶向癌症研究和治疗方法的开发。这项技术创新代表了空间生物学的重大突破，使研究人员能够以前所未有的细节分析复杂的生物系统。

2022年5月，美国健康情报公司Sema4以3.22亿美元收购了GeneDx。此次收购巩固了Sema4作为美国领先基因组检测提供者的地位，并增强了其健康资讯资料库，从而改善患者照护和治疗方案的开发。 GeneDx同样总部位于美国，专注于为罕见遗传疾病、遗传性疾病和癌症提供全面的诊断服务，这进一步增强了Sema4在精准医疗领域的能力。

基因检测面板市场由提供客製化检测面板设计、次世代定序、生物资讯分析、临床解读和药物基因体学等服务的营业单位所赚取的收益所构成。市场价值包括服务供应商销售的或包含在其服务产品中的任何相关产品的价值。基因检测面板市场还包括代谢失调检测面板、生殖健康检测面板、携带者筛检面板和神经系统疾病检测面板的销售。该市场的价值是指“出厂价”，即产品製造商或生产商销售的产品价值，无论是销售给其他营业单位（包括下游製造商、经销商、分销商和零售商）或直接销售给最终客户。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基因小组：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球基因组市场：成长率分析
  • 全球基因面板市场表现：规模与成长，2019-2024
  • 全球基因检测市场预测：规模与成长，2024-2029年，2034年
  • 全球基因面板：总目标市场（TAM）

第六章 市场细分

  • 全球基因组市场（依产品及服务划分）、实际及预测（2019-2024 年、2024-2029 年预测、2034 年预测）
  • 检测套组
  • 测试服务
  • 全球基因面板市场（依技术划分）：2019-2024 年、2024-2029 年、2034 年表现及预测
  • 基于扩增子
  • 杂交基地
  • 其他技术
  • 全球基因组市场：设计、现况及预测，2019-2024 年、2024-2029 年、2034 年
  • 预先设计的基因组
  • 客製化基因面板
  • 全球基因面板市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症风险评估
  • 先天性疾病的诊断
  • 药物基因组学
  • 其他用途
  • 全球基因组市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 研究机构
  • 医院
  • 诊断中心
  • 製药公司
  • 其他最终用户
  • 全球基因检测试剂盒市场：依检测套件类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 预先设计的基因面板
  • 客製化基因面板
  • 全球基因面板市场：依检测服务（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症风险评估小组
  • 药物基因组学测试小组
  • 神经系统疾病专家小组
  • 心血管疾病专家小组
  • 罕见疾病专家组

第七章 区域和国家分析

  • 全球基因面板市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球基因面板市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 基因面板市场：竞争格局
  • 基因组市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Intermountain Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Agilent Technologies Inc.
  • Illumina Inc.
  • Qiagen Inc.
  • OPKO Health Inc.
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Invitae Corp.
  • Integrated DNA Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Novogene Corporation
  • Fulgent Genetics Inc.
  • MedGenome Inc.
  • OriGene Technologies Inc.
  • Centogene AG
  • Blueprint Genetics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年基因检测市场：哪些国家将提供新机会
  • 2029 年基因检测市场：细分领域蕴含新机会
  • 2029 年基因面板市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r34056u

Gene panels are a set of specific genes selected for testing in a single assay to analyze genetic variations associated with particular diseases or conditions. They are utilized for diagnosing genetic disorders, detecting inherited diseases, and enabling personalized treatment plans by examining multiple genes simultaneously, particularly in cancer, rare diseases, and other genetic conditions.

The primary gene panel products and services include test kits and testing services. Test kits are pre-packaged tools containing all necessary reagents and instructions for genetic analysis. These panels employ various technologies, such as amplicon-based and hybridization-based methods, and can be either predesigned or customized. They are applied in cancer risk assessment, congenital disease diagnosis, pharmacogenetics, and other areas, serving end users such as research institutes, hospitals, diagnostic centers, pharmaceutical companies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The gene panel market research report is one of a series of new reports from The Business Research Company that provides gene panel market statistics, including gene panel industry global market size, regional shares, competitors with a gene panel market share, detailed gene panel market segments, market trends and opportunities, and any further data you may need to thrive in the gene panel industry. This gene panel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene panel market size has grown rapidly in recent years. It will grow from $2.14 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to the rising prevalence of hereditary disorders, growing necessity for genetic screening, increasing research and development activities, rising prevalence of congenital diseases, and increasing demand for advanced treatment options.

The gene panel market size is expected to see rapid growth in the next few years. It will grow to $4.33 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to an increasing number of chronic diseases, increasing cancer cases, increasing awareness of genetic testing, and increasing government initiatives and healthcare spending. Major trends in the forecast period include the advancement of gene panel technology, strategic collaboration, personalized treatment, the integration of artificial intelligence, and advanced bioinformatics tools.

The forecast of 15.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of next-generation sequencing (NGS) gene panels sourced from South Korea and the UK, thereby delaying genetic disease diagnoses and elevating molecular pathology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cancer is expected to drive the growth of the gene panel market. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade and damage surrounding tissues and organs. Factors such as aging populations, lifestyle changes, environmental exposures, and advancements in detection and diagnostic technologies are contributing to the increasing number of cancer cases. Gene panels play a crucial role in cancer diagnosis by enabling comprehensive genetic testing to identify mutations and alterations in specific genes, facilitating personalized treatment strategies and improving patient outcomes. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that an estimated 9.7 million people died from cancer in 2022, with 20 million new cases recorded. Lung cancer was the most prevalent, accounting for 12.4% of all new cases, with 2.5 million diagnoses worldwide. This increasing cancer burden continues to drive demand for gene panel testing.

Leading companies in the gene panel market are focusing on developing advanced oncology panels to enhance the accuracy, efficiency, and comprehensiveness of cancer diagnostics and personalized treatment approaches. Oncology panels are specialized gene panels that analyze multiple genes associated with cancer, identifying genetic mutations and alterations to aid in diagnosis, prognosis, and treatment planning. For instance, in May 2023, Vizgen Inc., a US-based biotechnology company, introduced the MERFISH PanCancer Pathways Panel, providing a customizable option for scientists exploring spatial genomics. These predesigned panels are optimized for various research applications, including cancer studies, and offer enhanced error robustness for reliable and reproducible results. By integrating spatial information with gene expression data, the panels provide deeper insights into tumor microenvironments and cellular interactions, advancing targeted cancer research and therapeutic development. This innovation marks a significant breakthrough in spatial biology, allowing researchers to analyze complex biological systems with unprecedented detail.

In May 2022, Sema4, a US-based health intelligence company, acquired GeneDx in a $322 million transaction. This acquisition bolsters Sema4's position as a leading provider of genomic testing in the U.S., enhancing its health information database to improve patient care and therapeutic development. GeneDx, also based in the U.S., specializes in comprehensive diagnostic services for rare genetic disorders, inherited diseases, and cancers, further strengthening Sema4's capabilities in precision medicine.

Major players in the gene panel market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Intermountain Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., OPKO Health Inc., Myriad Genetics Inc., Guardant Health Inc., Invitae Corp., Integrated DNA Technologies Inc., Bio-Rad Laboratories Inc., Novogene Corporation, Fulgent Genetics Inc., MedGenome Inc., OriGene Technologies Inc., Centogene AG, Blueprint Genetics Inc., BIONEER Corporation, BGI Group Ltd., Vizgen Inc., Primbio Research Institute LLC.

North America was the largest region in the gene panel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene panel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene panel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene panel market consists of revenues earned by entities by providing services such as custom panel design, next-generation sequencing, bioinformatics analysis, clinical interpretation, and pharmacogenomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene panel market also includes sales of metabolic disorder panels, reproductive health panels, carrier screening panels, and neurological disorder panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Panel Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene panel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene panel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene panel market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Services: Test Kits; Testing Services
  • 2) By Technology: Amplicon-Based; Hybridization-Based; Other Technologies
  • 3) By Design: Predesigned Gene Panel; Customized Gene Panel
  • 4) By Application: Cancer Risk Assessment; Diagnosis Of Congenital Diseases; Pharmacogenetics; Other Applications
  • 5) By End-User: Research Institutes; Hospital; Diagnosis Centers; Pharmaceutical Companies; Other End-Users
  • Subsegments:
  • 1) By Test Kits: Predesigned Gene Panels; Customized Gene Panels
  • 2) By Testing Services: Cancer Risk Assessment Panels; Pharmacogenetic Testing Panels; Neurological Disorder Panels; Cardiovascular Disease Panels; Rare Disease Panels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Intermountain Healthcare; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; Qiagen Inc.; OPKO Health Inc.; Myriad Genetics Inc.; Guardant Health Inc.; Invitae Corp.; Integrated DNA Technologies Inc.; Bio-Rad Laboratories Inc.; Novogene Corporation; Fulgent Genetics Inc.; MedGenome Inc.; OriGene Technologies Inc.; Centogene AG; Blueprint Genetics Inc.; BIONEER Corporation; BGI Group Ltd.; Vizgen Inc.; Primbio Research Institute LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Panel Market Characteristics

3. Gene Panel Market Trends And Strategies

4. Gene Panel Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Panel Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Gene Panel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Gene Panel Market Growth Rate Analysis
  • 5.4. Global Gene Panel Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Gene Panel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Gene Panel Total Addressable Market (TAM)

6. Gene Panel Market Segmentation

  • 6.1. Global Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Kits
  • Testing Services
  • 6.2. Global Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amplicon-Based
  • Hybridization-Based
  • Other Technologies
  • 6.3. Global Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predesigned Gene Panel
  • Customized Gene Panel
  • 6.4. Global Gene Panel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Risk Assessment
  • Diagnosis Of Congenital Diseases
  • Pharmacogenetics
  • Other Applications
  • 6.5. Global Gene Panel Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Institutes
  • Hospital
  • Diagnosis Centers
  • Pharmaceutical Companies
  • Other End-Users
  • 6.6. Global Gene Panel Market, Sub-Segmentation Of Test Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predesigned Gene Panels
  • Customized Gene Panels
  • 6.7. Global Gene Panel Market, Sub-Segmentation Of Testing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Risk Assessment Panels
  • Pharmacogenetic Testing Panels
  • Neurological Disorder Panels
  • Cardiovascular Disease Panels
  • Rare Disease Panels

7. Gene Panel Market Regional And Country Analysis

  • 7.1. Global Gene Panel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Gene Panel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Panel Market

  • 8.1. Asia-Pacific Gene Panel Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Panel Market

  • 9.1. China Gene Panel Market Overview
  • 9.2. China Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Panel Market

  • 10.1. India Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Panel Market

  • 11.1. Japan Gene Panel Market Overview
  • 11.2. Japan Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Panel Market

  • 12.1. Australia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Panel Market

  • 13.1. Indonesia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Panel Market

  • 14.1. South Korea Gene Panel Market Overview
  • 14.2. South Korea Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Panel Market

  • 15.1. Western Europe Gene Panel Market Overview
  • 15.2. Western Europe Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Panel Market

  • 16.1. UK Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Panel Market

  • 17.1. Germany Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Panel Market

  • 18.1. France Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Panel Market

  • 19.1. Italy Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Panel Market

  • 20.1. Spain Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Panel Market

  • 21.1. Eastern Europe Gene Panel Market Overview
  • 21.2. Eastern Europe Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Panel Market

  • 22.1. Russia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Panel Market

  • 23.1. North America Gene Panel Market Overview
  • 23.2. North America Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Panel Market

  • 24.1. USA Gene Panel Market Overview
  • 24.2. USA Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Panel Market

  • 25.1. Canada Gene Panel Market Overview
  • 25.2. Canada Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Panel Market

  • 26.1. South America Gene Panel Market Overview
  • 26.2. South America Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Panel Market

  • 27.1. Brazil Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Panel Market

  • 28.1. Middle East Gene Panel Market Overview
  • 28.2. Middle East Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Panel Market

  • 29.1. Africa Gene Panel Market Overview
  • 29.2. Africa Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Panel Market Competitive Landscape And Company Profiles

  • 30.1. Gene Panel Market Competitive Landscape
  • 30.2. Gene Panel Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Intermountain Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Gene Panel Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. Qiagen Inc.
  • 31.4. OPKO Health Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. Guardant Health Inc.
  • 31.7. Invitae Corp.
  • 31.8. Integrated DNA Technologies Inc.
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. Novogene Corporation
  • 31.11. Fulgent Genetics Inc.
  • 31.12. MedGenome Inc.
  • 31.13. OriGene Technologies Inc.
  • 31.14. Centogene AG
  • 31.15. Blueprint Genetics Inc.

32. Global Gene Panel Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Panel Market

34. Recent Developments In The Gene Panel Market

35. Gene Panel Market High Potential Countries, Segments and Strategies

  • 35.1 Gene Panel Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Gene Panel Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Gene Panel Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer